[HTML][HTML] The relationship between CT value and clinical outcomes in renal patients with COVID-19

S Ashrafi, P Pourahmad Kisomi… - … Urology and Nephrology, 2023 - Springer
Purpose Concomitant kidney diseases raise the mortality rate due to the SARS-CoV-2 virus
as an independent factor. Although a qualitative PCR test's result is sufficient for diagnosis …

COVID‐19 in lung transplant recipients: A single‐center experience

S Turkkan, MA Beyoglu, MF Sahin… - Transplant Infectious …, 2021 - Wiley Online Library
Abstract Background Coronavirus disease 2019 (COVID‐19) is a global health problem.
However, the course of this disease in immunosuppressed patients remains unknown. This …

[HTML][HTML] Black-white risk differentials in pediatric COVID-19 hospitalization and intensive care unit admissions in the USA

L Holmes Jr, C Wu, R Hinson, E Dias, C Nelson… - Journal of Racial and …, 2023 - Springer
Purpose The COVID-19 morbidity with SARS-CoV-2 as a causative pathogenic microbe
remains a pandemic with children experiencing less mortality but with severe …

Comparison of effectiveness and safety of nirmatrelvir/ritonavir versus sotrovimab for COVID-19: a systematic review and meta-analysis

B Amani, B Amani - Expert Review of Anti-infective Therapy, 2024 - Taylor & Francis
Background This study aims to compare the effectiveness and safety of nirmatrelvir/ritonavir
(Paxlovid) and sotrovimab for coronavirus disease 2019 (COVID-19). Methods A search was …

[HTML][HTML] The cause–effect dilemma of hematologic changes in COVID-19: one year after the start of the pandemic

I Youssry, D Abd Elaziz, N Ayad, I Eyada - Hematology Reports, 2022 - mdpi.com
COVID-19 is a systemic infection that leads to multisystem affection, including hematological
changes. On the other hand, the patients who have certain hematological diseases are more …

SARS-CoV-2 инфекция у реципиентов почечного трансплантата

ИГ Ким, ЛЮ Артюхина, НФ Фролова… - Нефрология и …, 2021 - elibrary.ru
Цель исследования: анализ особенностей клинического течения, факторов риска
неблагоприятного исхода и возможностей терапии COVID-19 у реципиентов почечного …

SARS‐CoV‐2 antibody responses in solid organ transplant recipients

FN Zervou, NM Ali, HJ Neumann… - Transplant Infectious …, 2021 - Wiley Online Library
Antibody responses among immunocompromised solid organ transplant recipients (SOT)
infected with Severe Acute Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) may be …

[HTML][HTML] Liver transplantation during global COVID-19 pandemic

M Alfishawy, N Nso, M Nassar… - World Journal of …, 2021 - ncbi.nlm.nih.gov
Abstract The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
disease respiratory syndrome coronavirus-2 has significantly impacted the health care …

[HTML][HTML] Humoral and cellular immune response after severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccination in heart transplant …

A Casenaz, S Grosjean, LS Aho-Glélé, JB Bour… - Frontiers in …, 2022 - frontiersin.org
Introduction Heart transplant (HT) recipients have a high risk of developing severe COVID-
19. Immunoglobulin G antibodies are considered to provide protective immunity and T-cell …

[HTML][HTML] The impact of COVID-19 on kidney transplant care

C Zhang, L Kodali, G Mour, C Jadlowiec… - Frontiers in …, 2023 - frontiersin.org
The SARS-CoV-2 virus precipitated the coronavirus 2019 (COVID-19) pandemic, which
placed considerable strain on healthcare systems and necessitated immediate and rapid …